20

nanotimes

Companies Facts

ARWR-Business highlights:

• Began formation of Calando Scientific Advisory Board with the appointment of John J. Rossi, Ph.D. to guide future development of CALAA-01, contribute to partnering activities, initiate new clinical candidates, and expand the RONDEL™ delivery system.

• Increased Arrowhead’s investment in Ablaris Therapeutics to $1.3 million, secured an additional $1.6 million of outside capital, and retained 64% equity in the company.

• Increased investment in Calando Pharmaceuticals via debt conversion and the purchase of preferred stock.

• Completed sale of Unidym to Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based elec- tronics company, for an upfront payment of $5.0 million in Wisepower stock and convertible bonds, retaining upside potential for Unidym stockhol- ders, including Arrowhead, with up to $140m on in earn-out payments and substantially reducing Arrowhead’s burn rate. http://www.arrowheadresearch.com

ceutical industry over the last 11 years, has been spun out from Avantium Holding BV in a manage- ment buy-out to create Crystallics.

A

Crystallics has developed a number of unique and proprietary technologies both in hardware and software, including High Throughput X-ray Powder Diffraction (HT-XRPD) technology and laboratory informatics, data analysis and predictive models. http://www.crystallics.com

vantium Pharma BV, a leader in solid state research and pre-formulation for the pharma-

D

avid Edwards is the new Chief Executive Officer of the Singaporean Nanostart (OTCQX: NAS-

RY) holding BioMers Pte Ltd. The top executive will be leveraging his extensive experience in building brands to drive BioMers’ commercial expansion and launch of flagship product, SimpliClear™.

Established in 2005, BioMers is a spin-off company from the National University of Singapore, where the technology was invented. BioMers is a medical device company that has developed novel polymer composite products for numerous biomedical ap- plications. The company’s flagship product is the SimpliClear™ braces system, which is the world’s first and only aesthetic solution for all types of orthodon- tic treatments. This translucent, almost invisible bra- ces system is customized to each patient, providing faster and better results. http://www.biomersbraces.com

B

iotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announ-

ced the further expansion of its successful family of sample preparation products with the launch of EVOLUTE WAX. The Company is a mixed-mode weak anion exchanger, developed for the extraction of strongly acidic analytes from aqueous samples. The resin-based sorbent is surface modified with well defined hydroxyl-functional oligomers, imparting excellent water wettability. An optimized combina- tion of non-polar (hydrophobic), polar (hydrophilic) and anion exchange interactions allows efficient extraction of strongly acidic analytes of wide ranging polarities. http://www.biotage.com

11-04 :: April/May 2011